HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsPricing
Theme
Help Login Register
Market News Stocks News ETF News Crypto News

Lexicon Pharmaceuticals, Inc.

Contributing Author

Recent Articles by Lexicon Pharmaceuticals, Inc.

7 hours
Data Demonstrating Sotagliflozin Reduces the Risk of Clinically Important Hypoglycemic Events in Adults with Type 1 Diabetes When Added to Insulin Presented at the 85th Scientific Sessions of the American Diabetes Association (ADA) LXRX GlobeNewswire
Jun-18
Lexicon to Present Data at the 85th Scientific Sessions of the American Diabetes Association (ADA) LXRX GlobeNewswire
May-29
Lexicon Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference LXRX GlobeNewswire
May-19
SONATA-HCM Study Design Presented at Heart Failure 2025, the Annual Congress of the Heart Failure Association of the European Society of Cardiology LXRX GlobeNewswire
May-13
Lexicon Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Updates LXRX GlobeNewswire
May-06
Lexicon Pharmaceuticals to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference LXRX GlobeNewswire
May-06
Lexicon Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025 LXRX GlobeNewswire
Affiliate • Advertise • Theme Settings • Contact • Help • Privacy • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.

Upgrade your FINVIZ experience

Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.

Learn more about FINVIZ*Elite